Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Telix Pharmaceuticals Ltd (TLX) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Telix Pharmaceuticals Ltd. Table 2 shows the detailed insider transactions. This company's CIK number is 2007191.
Total stock buying since 2026: $996,738.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 67,935 | $996,738 | 0 | $0 | 1,111 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-04 | 67,935 | $996,738 | 0 | $0 | 0 | $0 |
| 2026-03 | 0 | $0 | 0 | $0 | 1,111 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-29 | Behrenbruch Christian (MD & Group CEO) | Buy | 33,435 | 14.87 | 497,178 |
| 2026-04-28 | Behrenbruch Christian (MD & Group CEO) | Buy | 34,500 | 14.48 | 499,560 |
| 2026-03-29 | Smith Darren Charlton (Group Chief Financial Officer) | Option Ex | 1,111 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of TLX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Telix Pharmaceuticals Ltd (symbol TLX, CIK number 2007191) see the Securities and Exchange Commission (SEC) website.